Biogen Inc (BIIB)

Gross profit margin

		Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021	Dec 31, 2020	Sep 30, 2020	Jun 30, 2020	Mar 31, 2020	Dec 31, 2019	Sep 30, 2019	Jun 30, 2019	Mar 31, 2019
Gross profit (ttm)	US$ in thousands	4,293,100	4,560,000	5,013,800	5,194,800	5,114,100	4,431,600	4,584,300	4,800,400	5,316,400	7,273,800	8,587,800	10,180,300	11,639,400	12,501,700	12,744,800	12,614,700	12,422,500	12,236,100	12,044,200	11,839,300
Revenue (ttm)	US$ in thousands	9,835,600	9,993,300	9,971,500	10,104,600	10,173,400	10,363,200	10,633,600	10,819,500	10,981,700	11,100,500	11,697,700	12,604,300	13,444,600	14,263,300	14,487,300	14,422,400	14,377,900	14,232,900	14,071,800	13,811,600
Gross profit margin		43.65%	45.63%	50.28%	51.41%	50.27%	42.76%	43.11%	44.37%	48.41%	65.53%	73.41%	80.77%	86.57%	87.65%	87.97%	87.47%	86.40%	85.97%	85.59%	85.72%

December 31, 2023 calculation

Gross profit margin = Gross profit (ttm) ÷ Revenue (ttm)
= $4,293,100K ÷ $9,835,600K
= 43.65%

Biogen Inc's gross profit margin has exhibited fluctuations over the past eight quarters. The trend indicates a gradual decline from Q1 2022 to Q4 2023, with margins decreasing from 77.95% to 74.24%. Notably, there was a significant drop in Q1 2023, where the margin fell to 78.35% from 76.98% in the previous quarter. Despite these fluctuations, the company has generally maintained a high gross profit margin above 74%, indicating efficient cost management in production and pricing strategies. Monitoring these fluctuations and understanding the underlying factors influencing the gross profit margin will be crucial for assessing Biogen Inc's operational performance and profitability in the future.